ABL has been ranked ‘Excellent’ for ELISPOT testing with EQAPOL external quality assurance program

We have 55+ years of deep bench expertise

On behalf of our CEO, Jarlath Keating and VP of Immunology, Franck Lemiale we’re sending a big congratulations to our entire lab for the outstanding performance on our latest round of ELISPOT testing as part of the EQAPOL proficiency testing program.

The results have just been revealed and our lab has scored 100 points out of a 100, with EQAPOL rating of “Excellent”. We are honored to have ranked #1 out of a prestigious list of institutions worldwide! This means our clients have chosen the right partner with us in helping them take their products through preclinical and clinical development. They can take comfort knowing our immunology testing abilities are up to par with the very best labs in our industry.

EQAPOL is an NIH-DAIDS-sponsored independent program to assess the scientific and technical proficiency of laboratories involved in HIV/AIDS research worldwide. ABL has consistently participated in this stringent, fully independent assessment of our performance for a number of years. EQAPOL allows us to benchmark ourselves twice a year against the prestigious participating labs throughout the world, helping us achieve and maintain technical excellence. ABL is also enrolled for participation in a number of its key platforms/assays.

ELISpot

We are in great company. Some of the prestigious participating research bodies include:

  • The Baylor Institute for Immunology Research (TX)
  • The Ragon Institute of MGH, MIT and Harvard (MA)
  • NIAID’s Vaccine Immune T-Cell and Antibody Laboratory (NVITAL) (MD)
  • The HIV Vaccine Trials Network (HVTN, WA)
  • Beth Daconess Medical Center (MA)
  • The US Military Research Program (USMHRP, MD)
  • The Swiss Laboratory of AIDS pathogenesis
  • The International AIDS Vaccine Initiative’s Human Immunology Laboratory (IAVI-HIL, UK)
  • Fraunhofer IBMT (Germany)
  • Department of Retrovirology (Bangkok)

ABL’s boutique immunological testing is highly customized for each study and we have 55+ years of deep scientific expertise to get it done.

The results have just been revealed and our lab has scored 100 points out of a 100, with EQAPOL rating of “Excellent”. We are honored to have ranked #1 out of a prestigious list of institutions worldwide! This means our clients have chosen the right partner with us in helping them take their products through preclinical and clinical development. They can take comfort knowing our immunology testing abilities are up to par with the very best labs in our industry.

EQAPOL is an NIH-DAIDS-sponsored independent program to assess the scientific and technical proficiency of laboratories involved in HIV/AIDS research worldwide. ABL has consistently participated in this stringent, fully independent assessment of our performance for a number of years. EQAPOL allows us to benchmark ourselves twice a year against the prestigious participating labs throughout the world, helping us achieve and maintain technical excellence. ABL is also enrolled for participation in a number of its key platforms/assays.

Follow us on social media!